Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the leading cause of dementia worldwide and remains incurable once it begins. Therefore, early and accurate diagnosis is essential for effective intervention. Leveraging recent advances in deep learning, this study proposes a novel diagnostic model based on the 3D-ResNet architecture to classify three cognitive states: AD, mild cognitive impairment (MCI), and cognitively normal (CN) individuals, using MRI data. The model integrates the strengths of ResNet and 3D convolutional neural networks (3D-CNN), and incorporates a special attention mechanism(SAM) within the residual structure to enhance feature representation. The study utilized the ADNI dataset, comprising 800 brain MRI scans. The dataset was split in a 7:3 ratio for training and testing, and the network was trained using data augmentation and cross-validation strategies. The proposed model achieved 92.33% accuracy in the three-class classification task, and 97.61%, 95.83%, and 93.42% accuracy in binary classifications of AD vs. CN, AD vs. MCI, and CN vs. MCI, respectively, outperforming existing state-of-the-art methods. Furthermore, Grad-CAM heatmaps and 3D MRI reconstructions revealed that the cerebral cortex and hippocampus are critical regions for AD classification. These findings demonstrate a robust and interpretable AI-based diagnostic framework for AD, providing valuable technical support for its timely detection and clinical intervention.

To compare the axial cranial ultrasound images of normal and open neural tube defect (NTD) fetuses using a deep learning (DL) model and to assess its predictive accuracy in identifying open NTD.It was a prospective case-control study. Axial trans-thalamic fetal ultrasound images of participants with open fetal NTD and normal controls between 14 and 28 weeks of gestation were taken after consent. The images were divided into training, testing, and validation datasets randomly in the ratio of 70:15:15. The images were further processed and classified using DL convolutional neural network (CNN) transfer learning (TL) models. The TL models were trained for 50 epochs. The data was analyzed in terms of Cohen kappa score, accuracy score, area under receiver operating curve (AUROC) score, F1 score validity, sensitivity, and specificity of the test.A total of 59 cases and 116 controls were fully followed. Efficient net B0, Visual Geometry Group (VGG), and Inception V3 TL models were used. Both Efficient net B0 and VGG16 models gave similar high training and validation accuracy (100 and 95.83%, respectively). Using inception V3, the training and validation accuracy was 98.28 and 95.83%, respectively. The sensitivity and specificity of Efficient NetB0 was 100 and 89%, respectively, and was the best.The analysis of the changes in axial images of the fetal cranium using the DL model, Efficient Net B0 proved to be an effective model to be used in clinical application for the identification of open NTD. · Open spina bifida is often missed due to the nonrecognition of the lemon sign on ultrasound.. · Image classification using DL identified open spina bifida with excellent accuracy.. · The research is clinically relevant in low- and middle-income countries..

PurposeAccurate cancer subtyping is crucial for effective treatment; however, it presents challenges due to overlapping morphology and variability among pathologists. Although deep learning (DL) methods have shown potential, their application to gigapixel whole slide images (WSIs) is often hindered by high computational demands and the need for efficient, context-aware feature aggregation. This study introduces LiteMIL, a computationally efficient transformer-based multiple instance learning (MIL) network combined with Phikon, a pathology-tuned self-supervised feature extractor, for robust and scalable cancer subtyping on WSIs. MethodsInitially, patches were extracted from TCGA-THYM dataset (242 WSIs, six subtypes) and subsequently fed in real-time to Phikon for feature extraction. To train MILs, features were arranged into uniform bags using a chunking strategy that maintains tissue context while increasing training data. LiteMIL utilizes a learnable query vector within an optimized multi-head attention module for effective feature aggregation. The models performance was evaluated against established MIL methods on the Thymic Dataset and three additional TCGA datasets (breast, lung, and kidney cancer). ResultsLiteMIL achieved 0.89 {+/-} 0.01 F1 score and 0.99 AUC on Thymic dataset, outperforming other MILs. LiteMIL demonstrated strong generalizability across the external datasets, scoring the best on breast and kidney cancer datasets. Compared to TransMIL, LiteMIL significantly reduces training time and GPU memory usage. Ablation studies confirmed the critical role of the learnable query and layer normalization in enhancing performance and stability. ConclusionLiteMIL offers a resource-efficient, robust solution. Its streamlined architecture, combined with the compact Phikon features, makes it suitable for integrating into routine histopathological workflows, particularly in resource-limited settings.

We developed and tested a deep-learning-based algorithm for the approximation of contrast agent dosage based on computed tomography (CT) scout images. We prospectively enrolled 817 patients undergoing clinically indicated CT imaging, predominantly of the thorax and/or abdomen. Patient weight was collected by study staff prior to the examination 1) with a weight scale and 2) as self-reported. Based on the scout images, we developed an EfficientNet convolutional neural network pipeline to estimate the optimal contrast agent dose based on patient weight and provide a browser-based user interface as a versatile open-source tool to account for different contrast agent compounds. We additionally analyzed the body-weight-informative CT features by synthesizing representative examples for different weights using in-context learning and dataset distillation. The cohort consisted of 533 thoracic, 70 abdominal and 229 thoracic-abdominal CT scout scans. Self-reported patient weight was statistically significantly lower than manual measurements (75.13 kg vs. 77.06 kg; p < 10-5, Wilcoxon signed-rank test). Our pipeline predicted patient weight with a mean absolute error of 3.90 {+/-} 0.20 kg (corresponding to a roughly 4.48 - 11.70 ml difference in contrast agent depending on the agent) in 5-fold cross-validation and is publicly available at https://tinyurl.com/ct-scout-weight. Interpretability analysis revealed that both larger anatomical shape and higher overall attenuation were predictive of body weight. Our open-source deep learning pipeline allows for the automatic estimation of accurate contrast agent dosing based on scout images in routine CT imaging studies. This approach has the potential to streamline contrast agent dosing workflows, improve efficiency, and enhance patient safety by providing quick and accurate weight estimates without additional measurements or reliance on potentially outdated records. The models performance may vary depending on patient positioning and scout image quality and the approach requires validation on larger patient cohorts and other clinical centers. Author SummaryAutomation of medical workflows using AI has the potential to increase reproducibility while saving costs and time. Here, we investigated automating the estimation of the required contrast agent dosage for CT examinations. We trained a deep neural network to predict the body weight from the initial 2D CT Scout images that are required prior to the actual CT examination. The predicted weight is then converted to a contrast agent dosage based on contrast-agent-specific conversion factors. To facilitate application in clinical routine, we developed a user-friendly browser-based user interface that allows clinicians to select a contrast agent or input a custom conversion factor to receive dosage suggestions, with local data processing in the browser. We also investigate what image characteristics predict body weight and find plausible relationships such as higher attenuation and larger anatomical shapes correlating with higher body weights. Our work goes beyond prior work by implementing a single model for a variety of anatomical regions, providing an accessible user interface and investigating the predictive characteristics of the images.

Alzheimer's disease (AD) progressively alters brain structure and function, yet the associated changes in large-scale brain network dynamics remain poorly understood. We applied the intrinsic ignition framework to resting-state functional MRI (rs-fMRI) data from AD patients, individuals with mild cognitive impairment (MCI), and cognitively healthy controls (HC) to elucidate how AD shapes intrinsic brain activity. We assessed node-metastability at the whole-brain level and in 7 canonical resting-state networks (RSNs). Our results revealed a progressive decline in dynamical complexity across the disease continuum. HC exhibited the highest node-metastability, whereas it was substantially reduced in MCI and AD patients. The cortical hierarchy of information processing was also disrupted, indicating that rich-club hubs may be selectively affected in AD progression. Furthermore, we used linear mixed-effects models to evaluate the influence of Amyloid-{beta} (A{beta}) and tau pathology on brain dynamics at both regional and whole-brain levels. We found significant associations between both protein burdens and alterations in node metastability. Lastly, a machine learning classifier trained on brain dynamics, A{beta}, and tau burden features achieved high accuracy in discriminating between disease stages. Together, our findings highlight the progressive disruption of intrinsic ignition across whole-brain and RSNs in AD and support the use of node-metastability in conjunction with proteinopathy as a novel framework for tracking disease progression.

To develop a multiparametric breast MRI radiomics and deep learning-based multimodal model for predicting preoperative Ki-67 expression status in breast cancer, with the potential to advance individualized treatment and precision medicine for breast cancer patients. We included 176 invasive breast cancer patients who underwent breast MRI and had Ki-67 results. The dataset was randomly split into training (70 %) and test (30 %) sets. Features from T1-weighted imaging (T1WI), diffusion-weighted imaging (DWI), T2-weighted imaging (T2WI), and dynamic contrast-enhanced MRI (DCE-MRI) were fused. Separate models were created for each sequence: T1, DWI, T2, and DCE. A multiparametric MRI (mp-MRI) model was then developed by combining features from all sequences. Models were trained using five-fold cross-validation and evaluated on the test set with receiver operating characteristic (ROC) curve area under the curve (AUC), accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and F1 score. Delong's test compared the mp-MRI model with the other models, with P < 0.05 indicating statistical significance. All five models demonstrated good performance, with AUCs of 0.83 for the T1 model, 0.85 for the DWI model, 0.90 for the T2 model, 0.92 for the DCE model, and 0.96 for the mp-MRI model. Delong's test indicated statistically significant differences between the mp-MRI model and the other four models, with P values < 0.05. The multiparametric breast MRI radiomics and deep learning-based multimodal model performs well in predicting preoperative Ki-67 expression status in breast cancer.

To conduct a systematic review and meta-analysis of the performance of radiomics, dosiomics and machine learning in generating toxicity prediction in thoracic radiotherapy. An electronic database search was conducted and dual-screened by independent authors to identify eligible studies for systematic review and meta-analysis. Data was extracted and study quality was assessed using TRIPOD for machine learning studies, RQS for Radiomics and RoB for dosiomics. 10,703 studies were identified, and 5252 entered screening. 106 studies including 23,373 patients were eligible for systematic review. Primary toxicity predicted was radiation pneumonitis (81), followed by esophagitis (12) and lymphopenia (4). Fourty-two studies studying radiation pneumonitis were eligible for meta-analysis, with pooled area-under-curve (AUC) of 0.82 (95% CI 0.79-0.85). Studies with machine learning had the best performance, with classical and deep learning models having similar performance. There is a trend towards an improvement of the performance of models with the year of publication. There is variability in study quality among the three study categories and dosiomic studies scored the highest among these. Publication bias was not observed. The majority of existing literature using radiomics, dosiomics and machine learning has focused on radiation pneumonitis prediction. Future research should focus on toxicity prediction of other organs at risk and the adoption of these models into clinical practice.

Differentiating between follicular thyroid adenoma (FTA), carcinoma (FTC), and follicular tumor with uncertain malignant potential (FT-UMP) remains challenging due to their overlapping ultrasound characteristics. This retrospective study aimed to enhance preoperative diagnostic accuracy by utilizing intra- and peritumoral radiomics based on ultrasound images. We collected post-thyroidectomy ultrasound images from 774 patients diagnosed with FTA (n = 429), FTC (n = 158), or FT-UMP (n = 187) between January 2018 and December 2023. Six peritumoral regions were expanded by 5%-30% in 5% increments, with the segment-anything model utilizing prompt learning to detect the field of view and constrain the expanded boundaries. A stepwise classification strategy addressing three tasks was implemented: distinguishing FTA from the other types (task 1), differentiating FTC from FT-UMP (task 2), and classifying all three tumors. Diagnostic models were developed by combining radiomic features from tumor and peritumoral regions with clinical characteristics. Clinical characteristics combined with intratumoral and 5% peritumoral radiomic features performed best across all tasks (Test set: area under the curves, 0.93 for task 1 and 0.90 for task 2; diagnostic accuracy, 79.9%). The DeLong test indicated that all peritumoral radiomics significantly improved intratumoral radiomics performance and clinical characteristics (p < 0.04). The 5% peritumoral regions showed the best performance, though not all results were significant (p = 0.01-0.91). Ultrasound-based intratumoral and peritumoral radiomics can significantly enhance preoperative diagnostic accuracy for FTA, FTC, and FT-UMP, leading to improved treatment strategies and patient outcomes. Furthermore, the 5% peritumoral area may indicate regions of potential tumor invasion requiring further investigation.

The surgeries in drug-resistant ulcerative colitis are determined by complex factors. This study evaluated the predictive performance of radiomics analysis on the basis of whether patients with ulcerative colitis in hospital were in the surgical or medical treatment group by discharge from hospital. This single-center retrospective cohort study used CT at admission of patients with US admitted from 2015 to 2022. The target of prediction was whether the patient would undergo surgery by the time of discharge. Radiomics features were extracted using the rectal wall at the level of the tailbone tip of the CT as the region of interest. CT data were randomly classified into a training cohort and a validation cohort, and LASSO regression was performed using the training cohort to create a formula for calculating the radiomics score. A total of 147 patients were selected, and data from 184 CT scans were collected. Data from 157 CT scans matched the selection criteria and were included. Five features were used for the radiomics score. Univariate logistic regression analysis of clinical information detected a significant influence of severity (p < 0.001), number of drugs used until surgery (p < 0.001), Lichtiger score (p = 0.024), and hemoglobin (p = 0.010). Using a nomogram combining these items, we found that the discriminatory power in the surgery and medical treatment groups was AUC 0.822 (95% confidence interval (CI) 0.841-0.951) for the training cohort and AUC 0.868 (95% CI 0.729-1.000) for the validation cohort, indicating a good ability to discriminate the outcomes. Radiomics analysis of CT images of patients with US at the time of admission, combined with clinical data, showed high predictive ability regarding a treatment strategy of surgery or medical treatment.

This study aims to create a reliable framework for grading esophageal cancer. The framework combines feature extraction, deep learning with attention mechanisms, and radiomics to ensure accuracy, interpretability, and practical use in tumor analysis. This retrospective study used data from 2,560 esophageal cancer patients across multiple clinical centers, collected from 2018 to 2023. The dataset included CT scan images and clinical information, representing a variety of cancer grades and types. Standardized CT imaging protocols were followed, and experienced radiologists manually segmented the tumor regions. Only high-quality data were used in the study. A total of 215 radiomic features were extracted using the SERA platform. The study used two deep learning models-DenseNet121 and EfficientNet-B0-enhanced with attention mechanisms to improve accuracy. A combined classification approach used both radiomic and deep learning features, and machine learning models like Random Forest, XGBoost, and CatBoost were applied. These models were validated with strict training and testing procedures to ensure effective cancer grading. This study analyzed the reliability and performance of radiomic and deep learning features for grading esophageal cancer. Radiomic features were classified into four reliability levels based on their ICC (Intraclass Correlation) values. Most of the features had excellent (ICC > 0.90) or good (0.75 < ICC ≤ 0.90) reliability. Deep learning features extracted from DenseNet121 and EfficientNet-B0 were also categorized, and some of them showed poor reliability. The machine learning models, including XGBoost and CatBoost, were tested for their ability to grade cancer. XGBoost with Recursive Feature Elimination (RFE) gave the best results for radiomic features, with an AUC (Area Under the Curve) of 91.36%. For deep learning features, XGBoost with Principal Component Analysis (PCA) gave the best results using DenseNet121, while CatBoost with RFE performed best with EfficientNet-B0, achieving an AUC of 94.20%. Combining radiomic and deep features led to significant improvements, with XGBoost achieving the highest AUC of 96.70%, accuracy of 96.71%, and sensitivity of 95.44%. The combination of both DenseNet121 and EfficientNet-B0 models in ensemble models achieved the best overall performance, with an AUC of 95.14% and accuracy of 94.88%. This study improves esophageal cancer grading by combining radiomics and deep learning. It enhances diagnostic accuracy, reproducibility, and interpretability, while also helping in personalized treatment planning through better tumor characterization. Not applicable.